|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.45 USD | +1.69% |
|
+2.19% | +20.32% |
| 05-21 | Cytokinetics Insider Sold Shares Worth $264,915, According to a Recent SEC Filing | MT |
| 05-11 | Cytokinetics Announces New Data Related to MYQORZO At ESC Heart Failure 2026 | CI |
| Capitalization | 10.38B 8.93B 8.17B 7.73B 14.27B 1,002B 14.51B 96.79B 37.86B 473B 38.95B 38.12B 1,649B | P/E ratio 2026 * |
-11.8x | P/E ratio 2027 * | -16.4x |
|---|---|---|---|---|---|
| Enterprise value | 9.31B 8B 7.32B 6.93B 12.79B 899B 13.01B 86.77B 33.94B 424B 34.92B 34.17B 1,478B | EV / Sales 2026 * |
85.2x | EV / Sales 2027 * | 24.2x |
| Free-Float |
98.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cytokinetics, Incorporated
| 1 day | +1.69% | ||
| 1 week | +2.19% | ||
| Current month | +19.51% | ||
| 1 month | +14.60% | ||
| 3 months | +12.71% | ||
| 6 months | +18.00% | ||
| Current year | +20.32% |
| 1 week | 73 |  | 79.12 |
| 1 month | 58.64 | | 80.2 |
| Current year | 58.43 | | 80.2 |
| 1 year | 29.81 | | 80.2 |
| 3 years | 25.98 | | 110.25 |
| 5 years | 17.72 | | 110.25 |
| 10 years | 5.75 | | 110.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Blum
CEO | Chief Executive Officer | 62 | 01/01/2007 |
Sung Lee
DFI | Director of Finance/CFO | 56 | 08/05/2024 |
| Chief Administrative Officer | 57 | 14/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Wysenski
BRD | Director/Board Member | 68 | 20/11/2020 |
Edward Kaye
BRD | Director/Board Member | 77 | 20/05/2016 |
B. Parshall
BRD | Director/Board Member | 71 | 07/02/2013 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.69% | +2.19% | +148.62% | +96.13% | 10.38B | |
| +0.79% | -1.12% | +36.17% | +78.77% | 49.39B | |
| +1.29% | -6.55% | +68.88% | +53.42% | 45.18B | |
| +0.47% | -6.97% | +58.97% | +454.52% | 23.28B | |
| +2.93% | -3.52% | -7.61% | -15.15% | 22.2B | |
| +0.42% | -1.66% | +39.54% | -21.38% | 17.43B | |
| +3.95% | +0.58% | +30.49% | -38.96% | 15.79B | |
| +1.95% | -11.54% | +37.64% | +205.85% | 13.26B | |
| +1.72% | -5.16% | +32.02% | - | 12.79B | |
| +12.87% | -5.59% | -25.49% | +964.88% | 12.3B | |
| Average | +2.81% | -5.13% | +41.92% | +197.57% | 22.2B | |
| Weighted average by Cap. | +2.10% | -3.93% | +42.39% | +148.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 109M 93.98M 85.98M 81.33M 150M 10.55B 153M 1.02B 399M 4.98B 410M 401M 17.36B | 387M 333M 305M 288M 532M 37.41B 542M 3.61B 1.41B 17.66B 1.45B 1.42B 61.53B |
| Net income | -806M -693M -634M -600M -1.11B -77.84B -1.13B -7.52B -2.94B -36.74B -3.02B -2.96B -128B | -653M -561M -514M -486M -897M -63.05B -913M -6.09B -2.38B -29.76B -2.45B -2.4B -104B |
| Net Debt | -1.07B -924M -845M -799M -1.48B -104B -1.5B -10.02B -3.92B -48.96B -4.03B -3.94B -171B | -998M -858M -785M -743M -1.37B -96.36B -1.4B -9.3B -3.64B -45.48B -3.74B -3.66B -158B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/05/26 | 78.77 $ | +3.03% | 2,377,488 |
| 19/05/26 | 76.45 $ | +1.69% | 2,399,087 |
| 18/05/26 | 75.18 $ | -0.88% | 1,798,155 |
| 15/05/26 | 75.85 $ | -3.55% | 1,829,793 |
| 14/05/26 | 78.64 $ | +1.84% | 2,349,146 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CYTK Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition